神經科學市場:現狀分析與預測(2022-2030年)

Neuroscience Market: Current Analysis and Forecast (2022-2030)

出版日期: 2023年05月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

由於神經系統疾病的患病率不斷增加以及神經科學研究的進步，神經科學市場預計將以 4% 左右的速度穩定增長。此外，神經系統疾病發病率和患病率的上升、人們對神經退行性疾??病的認識不斷增強以及腦外傷數量的增加也推動了該市場的增長。例如，據世界衛生組織稱，2021年將有超過5500萬人被診斷出患有癡呆症，每年新增病例近1000萬。2019年，全球有5000萬人被診斷患有癲癇症。

為了更好地了解神經科學行業的市場採用情況，市場包括北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、意大利、歐洲其他地區）、亞太地區（中國）、日本、印度）。、亞太地區其他地區）以及世界其他國家/地區。預計北美在預測期內將以顯著的複合年增長率增長。這主要是由於神經系統疾病的患病率不斷上升、醫療保健成本不斷上升以及該地區越來越多地採用先進的神經科學技術。

Neuroscience is a multidisciplinary field that incorporates phonetics, calculation, theory, brain science, and science. Neuroscience investigates the cellular, operational, behavioral, molecular, evolutionary, and therapeutic aspects of the neurotic system. Neuroscience research involves a variety of techniques, including brain imaging, electrophysiology, and genetic engineering, and is driving new discoveries in areas such as neurodegeneration, neuropsychiatric disorders, and neural engineering. Moreover, growing mergers and acquisitions between players or investments in research activities will also drive the growth of this market. For instance, in December 2020, Eli Lilly and Company announced that it will buy Win Therapeutics for USD 800 million in a drug bargain. As a result of the acquisition agreement, Eli Lilly & Company will develop a new method for drug discovery and development. This new gene therapy initiative will expand the company's research activities.

The neuroscience market is expected to grow at a steady rate of around 4% owing to the growing prevalence of neurological disorders and advancements in neuroscience research. Furthermore, the growth of this market is also driven owing to the rising incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. For instance, as per WHO, more than 55 million people were diagnosed with dementia in 2021, and there are nearly 10 million new cases every year. Also, in 2019, globally, 50 million people were diagnosed with epilepsy.

Based on component, the market is segmented into instruments, software, and services. The Instruments category is to witness a higher CAGR during the forecast period. These instruments provide accurate and detailed information about the brain, enabling clinicians to diagnose and treat neurological disorders more effectively. Moreover, advances in instrument technology have led to the development of brain-computer interfaces (BCIs), which allow patients with paralysis and other neurological conditions to communicate and control devices with their thoughts. The increasing demand for advanced instruments in neuroscience research and clinical applications is driving the growth of the neuroscience market.

On the basis of end-user, the market is categorized into hospitals, diagnostic laboratories, research, and academic institutes, and others. Among these, the hospitals held a significant share of the market in 2021. This is mainly due to the high preference of patients for hospitalization to have a more accurate diagnosis of their neurological diseases, increasing prevalence of neurological disorders, coupled with the rising demand for personalized medicine, is driving the growth of the healthcare provider segment in the neuroscience market.

For a better understanding of the market adoption of the neuroscience industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of neurological disorders, rising healthcare expenditure, and the growing adoption of advanced neuroscience technologies in the region. Additionally, +

Some of the major players operating in the market include: Carl ZEISS AG; Leica Microsystems; General Electric; Siemens; Koninklijke Philips N.V.; TOSHIBA CORPORATION; Hitachi, Ltd.; ESAOTE SPA; HAAG-STREIT GROUP; and Optofine Instruments Pvt. Ltd.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Neuroscience Market
2.2. Research Methodology of the Neuroscience Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE NEUROSCIENCE MARKET

6 NEUROSCIENCE MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY COMPONENT

7.1. Instruments
- 7.1.1. MRI Imaging System
- 7.1.2. Neuromicroscopy
7.2. Software
7.3. Services
- 7.3.1. Consulting Services
- 7.3.2. Installation Services
- 7.3.3. Maintenance Services

8 MARKET INSIGHTS BY END-USER

8.1. Hospitals
8.2. Diagnostic Laboratories
8.3. Research and Academic Institutes
8.4. Others

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World